Mechanistically, IRX3 promotes the transcription of CDK14 (Cyclin Dependent Kinase 14) by binding to its promoter, which in turn stabilizes β-catenin expression through restraining its ubiquitination degradation, thereby activating the canonical Wnt/β-catenin pathway and promoting GBM growth. Here, IRX3 is linked to glioblastoma.